INTRODUCTION
Ocular toxoplasmosis (OT), a potential blinding disease causes a high incidence of uveitis worldwide (Holland, Reference Holland2003), which is caused by the obligate intracellular parasite Toxoplasma gondii. In spite of extensive research on epidemiology, immunology and pathophysiology of the disease (Maenz et al. Reference Maenz, Schluter, Liesenfeld, Schares, Gross and Pleyer2014), many aspects of OT still remain unclear. After T. gondii infection, nearly all mouse lineages develop a T helper (Th)1-type immune response, although they present resistant or susceptible major histocompatibility complex (MHC) haplotypes (Gazzinelli et al. Reference Gazzinelli, Hakim, Hieny, Shearer and Sher1991, Reference Gazzinelli, Xu, Hieny, Cheever and Sher1992). It has been demonstrated that C57BL/6 (B6) mice are more susceptible to the parasite than BALB/c mice (Suzuki et al. Reference Suzuki, Yang and Remington1995).
Galectins, beta-galactoside-binding animal lectins, are differentially expressed by various immune cells as well as a wide range of other cell types (Liu and Rabinovich, Reference Liu and Rabinovich2010). So far, 15 members of the galectin family have been identified in vertebrates (Viguier et al. Reference Viguier, Advedissian, Delacour, Poirier and Deshayes2014). Some galectins such as galectin (Gal)-1, -3, -8 and -9 have wide tissue distribution, whereas others such as Gal-4, -5 and -6 exhibit tissue specificity (Panjwani, Reference Panjwani2014). Galectins can regulate microbial invasion via acting as pathogen recognition receptors, and have multiple roles in both innate and adaptive immune responses (Vasta, Reference Vasta2009; Baum et al. Reference Baum, Garner, Schaefer and Lee2014). Previous study has reported that Gal-3 can significantly alter the pathogenic course of T. gondii infection (Bernardes et al. Reference Bernardes, Silva, Ruas, Mineo, Loyola, Hsu, Liu, Chammas and Roque-Barreira2006). T cell Ig and mucin domain-containing molecule-3 (Tim-3) was firstly identified as a molecule specifically expressed on interferon (IFN)-γ-producing CD4+ Th1 and CD8+ Tc1 (cytotoxic) cells in mice (Anderson et al. Reference Anderson, Anderson, Bregoli, Hastings, Kassam, Lei, Chandwaskar, Karman, Su, Hirashima, Bruce, Kane, Kuchroo and Hafler2007). Studies further demonstrated that Tim-3 is expressed on cells of both innate and adaptive immune systems, including CD4+ regulatory T cells, monocytes/macrophages, dendritic cells (DCs), and natural killer cells (Hu et al. Reference Hu, Tang, Mor and Liao2016). Gal-9 is identified as a Tim-3 ligand and Gal-9/Tim-3 interaction acts as a specific inhibitor of Th1 and Th17 immune responses (Wu et al. Reference Wu, Thalhamer, Franca, Xiao, Wang, Hotta, Zhu, Hirashima, Anderson and Kuchroo2014). Gal-9/Tim-3 interaction also plays a crucial role in immune regulation. Gal-9 administration significantly decreased viral load, inhibited mucus production and diminished lung immunopathology caused by respiratory syncytial virus infections (Lu et al. Reference Lu, McCoy, Xu, Hu, Chen, Jiang, Han, Chen and Wang2015). Studies demonstrated that Gal-9 also binds to CD44 (Chiba et al. Reference Chiba, Baghdadi, Akiba, Yoshiyama, Kinoshita, Dosaka-Akita, Fujioka, Ohba, Gorman, Colgan, Hirashima, Uede, Takaoka, Yagita and Jinushi2012), CD137 (Liang and Qin, Reference Liang and Qin2013) and protein disulphide isomerase (PDI) (Kojima et al. Reference Kojima, Arikawa, Saita, Goto, Tsumura, Tanaka, Masunaga, Niki, Oomizu and Hirashima2011). CD44 is a transmembrane adhesion molecule that is present on a wide variety of cell types, including leucocytes and parenchymal cells, and is an important player in leucocyte trafficking (Sunil et al. Reference Sunil, Francis, Vayas, Cervelli, Choi, Laskin and Laskin2015). CD137 is a co-stimulatory member of the tumour necrosis factor (TNF) receptor family discovered on T cells undergoing activation (Kwon and Weissman, Reference Kwon and Weissman1989).
So far, the immunopathological mechanisms that lead to ocular toxoplasmic infection remain largely unknown. Currently, it is not clear what role of galectins play in OT and whether manipulating galectin binding to their receptors can influence the magnitude and effectiveness of T. gondii immunity, their expression patterns in the context of OT have thus far not been elucidated. In addition, the pathway involved in the induction of IFN-I by the interaction of Gal-9 and its receptors in ocular immunopathogenesis during T. gondii infection have not been reported. In this study, we seek to compare the expression levels of Gal-1, -3, -8, -9, the receptors of Gal-9 (Tim-3, CD44, CD137 and PDI), IFN-I (IFN-α and -β), IFN-II (IFN-γ) and IL-10 in the eyes between T. gondii-susceptible B6 and -resistant BALB/c mice after ocular T. gondii infection, and the roles of galectins in BALB/c mice during ocular T. gondii infection were investigated with the blockage of galectins by α-lactose in vivo. We demonstrated that the signalling of Gal-9 and its receptors (Tim-3 and CD137) may involve in the development of OT in ocular T. gondii-infected B6 mouse model, and IFN-I production may play a protective role during ocular T. gondii infection.
MATERIALS AND METHODS
Mice, parasite, intravitreal infection and treatment with α-lactose
B6 and BALB/c mice, female, aged 5–6 weeks were obtained from the Experiment Animal Center of Sun Yat-sen University (Guangzhou, China). All animals were maintained in specific-pathogen-free environment and had free access to a commercial basal diet and tap water ad libitum. Tachyzoites of T. gondii RH strain stored in our laboratory were propagated by intraperitoneal passage in Kunming mice at 4–5-day intervals. For intravitreal infection, according to Charles et al. (Reference Charles, Callegan and Blader2007) and modified, 1-μL parasite suspension containing 500 tachyzoits or the same volume of phosphate-buffered saline (PBS) was injected into one of the eye of per mice using a 10-μL Hamilton microsyringe. Some mice were injected intraperitoneally (i.p.) with 150 mm of α-lactose solution in PBS twice daily starting from 1 day post-infection (dpi) until the day mice were sacrificed. Animals were sacrificed at 12 h after the last treatment and their eyes and cervical lymph nodes (CLNs) were taken for further analysis (Sehrawat et al. Reference Sehrawat, Reddy, Rajasagi, Suryawanshi, Hirashima and Rouse2010). A total of 30 mice of each strain were used in the experiments: eight mice were intravitreally injected with 500 T. gondii tachyzoites, eight mice were intravitreally injected with 500 T. gondii tachyzoites and treated with α-lactose; seven mice were injected i.p. with α-lactose alone; and seven mice were intravitreally injected with equal volume of PBS as negative controls. Mice infected with T. gondii were sacrificed by CO2 asphyxiation for examination at 8 dpi. All experiments were performed in compliance with the requirements of the Animal Ethics Committee at Sun Yat-sen University.
Histopathological analysis
Mice were sacrificed by CO2 asphyxiation at 8 dpi, and the eyes were harvested and immediately fixed in 10% buffered natural formaldehyde (Guangzhou Chemical Reagent Factory, China) for 48 h. Five-micrometre-thick sections of the organs from each mouse, stained with haematoxylin and eosin (H&E) (Sigma-Aldrich), were evaluated for histological changes and parasite proliferations.
Measurement of mRNA expression using quantitative real-time reverse transcription-polymerase chain reaction (qRT–PCR)
Total RNA was extracted from the eye and CLN samples of each mouse using RNA Extraction kit (TaKaRa Bio, Inc., Tokyo, Japan) according to the manufacturer's protocol. The quality of total RNA was analysed by running 5 µL of each RNA sample on a 1·0% agarose gel stained with ethidium bromide. The quantity of total RNA was estimated by measuring the ratio of absorbance at 260 and 280 nm using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, DE, USA). First-strand cDNA was constructed from 1·0 µg of total RNA with oligo (dT) as primers using a PrimeScript 1st Strand cDNA Synthesis Kit (TaKaRa Bio, Inc.) following the manufacturer's protocol. cDNA was stored at −80 °C until use. To determine tissue mRNA levels of Gal-1, -3, -8 and -9, Tim-3, CD44, CD137, PDI, IFN-α, IFN-β, IFN-γ and IL-10, qRT–PCR was performed using SYBR Green QPCR Master Mix (TaKaRa Bio, Inc.) according to the manufacturer's instructions. For eye parasite loads, the levels of mRNA transcripts of T. gondii tachyzoite surface antigen 1 (SAG1) gene were measured by using qRT–PCR. Primers for the qRT–PCR are listed in Table 1. Briefly, a total of 10 µL reaction mixture contained 5·0 µL of SYBR® Premix Ex TaqTM (2×), 0·5 µL of each primer (10 pm), 3·0 µL of dH2O and 1·0 µL of cDNA (0·2 µg µL−1). Amplification was pre-denaturized for 30 s at 95 °C followed by 43 cycles of 5 s at 95 °C and 20 s at 60 °C with a LightCycler® 480 instrument (Roche Diagnostics, AL, USA). Values are means from triplicate measurements, specific mRNA expression levels were normalized to that of the housekeeping gene, β-actin and the results are expressed as fold change compared with uninfected controls.
Statistical analysis
Results of experimental studies were reported as mean ± s.d. Independent-sample t-test and one way ANOVA followed by LSD post hoc test were performed to determine the statistical significance of differences between samples by using SPSS software for windows (version 19·0; SPSS, Inc., IL, USA). All graphs were performed using GraphPad Prism software and a value of P < 0·05 was considered statistically significant.
RESULTS
B6 mice displayed significantly severer ocular pathology and higher ocular parasite loads than those in BALB/c mice
Compared with BALB/c mice, B6 mice developed severe ocular pathology characterized by an intense inflammatory response and severe necrosis as described previously, while BALB/c mice showed moderate inflammatory response and necrosis (Fig. 1A). To compare the parasite loads in the two strains of mice, the mRNA levels of T. gondii SAG1 were determined in the eyes. As expected, B6 mice showed a significantly higher parasite loads than those of BALB/c mice in the eyes and CLNs at 8 dpi (P < 0·001) (Fig. 1B).
B6 mice displayed significantly higher mRNA expressions of Gal-1, -3, -8 and -9 and the receptors of Gal-9 (Tim-3 and CD137) in the eyes and CLNs than those in BALB/c mice
To determine the expression of galectins supposed to be involved in acute experimental OT, our results showed that compared with uninfected control mice, there were significantly increased mRNA expression levels of Gal-1 (P < 0·05), -3 (P < 0·01), -8 (P < 0·05) and -9 (P < 0·01) in the eyes of T. gondii-infected B6 mice at 8 dpi; significantly increased Gal-8 (P < 0·05) in the CLNs of of B6 mice and significantly increased Gal-1 and -3 in the CLNs (P < 0·001) of both B6 and BALB/c mice (Fig. 2A). As shown in Fig. 2B, Tim-3 levels were significantly increased in the eyes (P < 0·01) and CLNs (P < 0·01) of both B6 and BALB/c mice. CD137 levels were also significantly increased in the eyes and CLNs of both B6 (P < 0·001) and BALB/c (P < 0·01) mice. However, compared with BALB/c mice, there were significantly increased Gal-1 (P < 0·05), -3 (P < 0·01) and -9 (P < 0·01) in the eyes and significantly increased Tim-3 (P < 0·05) and CD137 (P < 0·001 and P < 0·05, respectively) in both the eyes and CLNs of B6 mice. These results indicate that ocular T. gondii infection leads to the induction of expressions of Gal-9 and its receptors (Tim-3 and CD137) in susceptible B6 mice, and the induction of Gal-1 or -3 in both susceptible B6 and resistant BALB/c mice.
BALB/c mice displayed significantly higher expressions of IFN-I (IFN-α and -β) in the eyes and CLNs than those in B6 mice
To assess the differences in cytokine production between the two strains of mice after ocular infection with T. gondii, the mRNA expressions of IFN-I (IFN-α and -β), IFN-II (IFN-γ), IL-10 and IL-6 in the eyes and CLNs were determined by using qRT–PCR. As shown in Fig. 3A, compared with uninfected control mice, there were significantly deceased IFN-α and -β in both the eyes (P < 0·05) and CLNs (P < 0·05) of B6 mice, but significantly increased IFN-α and -β in both the eyes (P < 0·05) and CLNs (P < 0·05) of BALB/c mice at 8 dpi; there were significant increased IFN-γ in the eyes (P < 0·001) of both B6 and BALB/c mice, and in the CLNs (P < 0·001) of B6 mice at 8 dpi. As shown in Fig. 3B, compared with uninfected control mice, there were significantly increased IL-6 and -10 in both the eyes (P < 0·001) and CLNs (P < 0·01) of B6 mice, and significantly increased IL-10 in the CLNs (P < 0·05) of BALB/c mice at 8 dpi.
Ocular immunopathology in BALB/c mice was independent of galectins
To study the role of galectins in resistant BALB/c mice against ocular infection with T. gondii, BALB/c mice were intravitreally infected with T. gondii. As shown in Fig. 4, moderate inflammation and necrosis, and obvious tachyzoites or pseudocysts were observed in the eye tissues of BALB/c mice with or without α-lactose treatment. No significant differences of parasite loads in the eyes and CLNs were detected between the two groups.
Furthermore, the cytokine expressions were measured in BALB/c mice with or without α-lactose treatment. As shown in Fig. 5, compared with uninfected controls, the levels of IFN-α, -β and -γ in the eyes of T. gondii-infected BALB/c mice either with α-lactose treatment (P < 0·05, <0·05 and <0·001, respectively) or without α-lactose treatment (P < 0·05, <0·05 and <0·001, respectively) were significantly increased after ocular T. gondii infection; however, the expressions of IFN-α, -β and -γ had no significant differences between these two groups (Fig. 5A). Similarly, the levels of IL-6 and -10 in the eyes of T. gondii-infected BALB/c mice either with α-lactose treatment (P < 0·01 and <0·05, respectively) or without α-lactose treatment (P < 0·01 and <0·05, respectively) were significantly increased after ocular T. gondii infection but had no significant differences between these two groups (Fig. 5B). Because both ocular pathology and parasite loads showed no differences between T. gondii-infected BALB/c mice with or without α-lactose treatment, which suggests that galectins did not play an essential role for ocular immunopathology in genetic resistant BALB/c mice. In contrast, the severity of ocular pathology in susceptible B6 mice may be related to the expressions of galectins.
DISCUSSION
Toxoplasma gondii infection is the most common cause of posterior uveitis worldwide (Holland, Reference Holland2004). At present, laboratory mice continue to be the experimental model of choice for the investigation of most aspects of OT (Dukaczewska et al. Reference Dukaczewska, Tedesco and Liesenfeld2015). Using eye inoculation by injecting 100 RH tachyzoites into the anterior chamber of eyes, our previous work demonstrated that genetic factors of the host as well as the parasite strain are critical in determining susceptibility to experimental OT in murine models (Lu et al. Reference Lu, Huang, Hu and Kasper2005). In this study, we investigated the role of galectins in the regulation of immune responses against ocular infection with T. gondii in susceptible B6 and resistant BALB/c mice by intravitreal injection of 500 RH tachyzoits. We firstly determined the expressions of Gal-1, -3, -8, -9 and its receptors (Tim-3, CD44, CD137 and DPI), IFN-α, IFN-β, IFN-γ, IL-6 and IL-10 in naive and T. gondii-infected B6 and BALB/c mice. Finally, blockage of galectins by treatment with α-lactose on the BALB/c background mice was used to investigate the role of galectins against ocular immunopathology. Taken together, our data indicate that acute ocular T. gondii infection results in increased Gal-1 and -3, especially Gal-9/Tim-3 and Gal-9/CD137 mRNA expressions in the eyes of susceptible B6 mice; however, the blockage of galectins did not change the severity of ocular toxoplasmic immunopathology and parasite loads in BALB/c mice. In addition, IFN-I may play a protective role in experimental OT but their expressions may be under genetic control.
In the current study, intraocular infection with tachyzoites of T. gondii induces elevated levels of IFN-γ that lead to the development of ocular immunopathology in both genetically susceptible B6 and resistant BALB/c mice; however, T. gondii-infected BALB/c mice developed lighter immunopathology. It has been reported that differentially expressed molecules in susceptible mice versus resistant mice are key to the development of immunopathology of T. gondii infection (Liesenfeld et al. Reference Liesenfeld, Kosek, Remington and Suzuki1996; Buzoni–Gatel et al. Reference Buzoni–Gatel, Debbabi, Mennechet, Martin, Lepage, Schwartzman and Kasper2001; Liesenfeld, Reference Liesenfeld2002). T. gondii infection elicits a strong Th1 response including with IFN-γ release (Suzuki et al. Reference Suzuki, Orellana, Schreiber and Remington1988). IFN-γ is required for an efficient activation of macrophages, and macrophages are of critical importance in antitoxoplasmic activity (Deckert-Schlüter et al. Reference Deckert-Schlüter, Rang, Weiner, Huang, Wiestler, Hof and Schlüter1996). There is a remarkable difference in susceptibility to peroral infection with T. gondii among inbred strains of mice. IFN-γ mediates necrosis in the ilea of B6 mice after the ME49 strain of T. gondii infection, whereas the same cytokine plays a critical role in the resistance of genetically resistant BALB/c mice (Liesenfeld et al. Reference Liesenfeld, Kosek, Remington and Suzuki1996). Here we observed significantly higher levels of IFN-γ, IL-6 and IL-10 in the eyes and CLNs of B6 compared with BALB/c mice after ocular T. gondii infection. Following intraocular reinfection with the avirulent PRU strain of T. gondii, strongly enhanced production of IL-6 and IFN-γ in the aqueous humour of eyes was measured in B6 mice (Rochet et al. Reference Rochet, Brunet, Sabou, Marcellin, Bourcier, Candolfi and Pfaff2015). We previously reported that BALB/c mice when rendered deficient in IL-10 develop severe ocular immunopathology upon T. gondii infection via ocular inoculation (Lu et al. Reference Lu, Huang and Kasper2003), here we further demonstrated the key role of IL-10 in preventing the development of ocular immunopathology.
We found increased levels of Gal-1, -3, -8, -9, Tim-3 and CD137 in the eyes and Gal-8 in the CLNs of B6 mice; in addition, increased Gal-1 and -3, Tim-3 and CD137 were detected in the CLNs of both strains of mice after infection. After ocular Pseudomonas aeruginosa infection, subconjunctival injection of recombinant Gal-1 can significantly diminish corneal lesion severity through regulation of corneal infiltration of neutrophils and T cells, and modulation of Th17 and regulatory T (Treg) cell responses in the cornea as well as local draining lymph nodes (Suryawanshi et al. Reference Suryawanshi, Cao, Thitiprasert, Zaidi and Panjwani2013). In corneal epithelium, an association of Gal-3 with cell surface mucins contributes to maintenance of the ocular surface epithelial barrier function (Argüeso et al. Reference Argüeso, Guzman-Aranguez, Mantelli, Cao, Ricciuto and Panjwani2009). Gal-8 can promote the differentiation of Treg and Th2 cells by modulating IL-2 and TGFβ signalling (Sampson et al. Reference Sampson, Suryawanshi, Chen, Rabinovich and Panjwani2016). Gal-8 attenuates the retinal pathology in a murine model of experimental autoimmune uveitis through enhancing the Treg cell response and inhibiting inflammation of the retina (Sampson et al. Reference Sampson, Hasegawa, Mulki, Suryawanshi, Jiang, Chen, Rabinovich, Connor and Panjwani2015). Tim-3/Gal-9 interaction plays a critical role at influencing the expression of herpes simplex virus induced ocular lesions (Sehrawat et al. Reference Sehrawat, Suryawanshi, Hirashima and Rouse2009). Similarly, our data in this study indicated that Gal-9/Tim-3 and/or Gal-9/CD137 interaction may play a role in OT of B6 mice. However, after ocular T. gondii infection, no differences in ocular immunopathology or parasite loads were detected in BALB/c mice with α-lactose treatment compared to those without α-lactose treatment. Therefore, our data suggest that Gal-1, -3, -8 and -9 and its receptors were not key players in preventing ocular immunopathology induced by T. gondii in resistant BALB/c mice.
We found significantly higher IFN-α/β expressions in T. gondii-infected BALB/c mice but significantly lower IFN-α/β expressions in infected B6 mice. IFN-I signalling through the IFN-α/β receptor (Ifnar) is critically important for innate immune defence (Sadler and Williams, Reference Sadler and Williams2008). A pivotal effect of Ifnar/IFN-β signalling in retinal microglia and macrophages that reduce chronic inflammation and pathological angiogenesis in age-related macular degeneration and thereby limit the development of choroidal neovascularization lesions (Lückoff et al. Reference Lückoff, Caramoy, Scholz, Prinz, Kalinke and Langmann2016). It has been reported that T. gondii is capable of eliciting IFN-α/β production in the serum of infected mice (Freshman et al. Reference Freshman, Merigan, Remington and Brownlee1966). IFN-α/β production is an important factor associated with acute toxoplasmosis-induced immunosuppression in NMR1 mice (Swiss-type mice) infected with the RH strain of T. gondii (Diez et al. Reference Diez, Galdeano, Nicolas and Cisterna1989). Using retinal pigment epithelial cell in vitro model system to evaluate T. gondii replication and the regulation of this replication by cytokines, it demonstrated that pretreatment of cultures with recombinant human IFN-α, -β or -γ prior to inoculation inhibited T. gondii replication in a dose-dependent manner, by the induction of indoleamine 2,3-dioxygenase (Nagineni et al. Reference Nagineni, Pardhasaradhi, Martins, Detrick and Hooks1996). In vivo study showed that recombinant murine IFN-β protected mice against a lethal infection of T. gondii (Orellana et al. Reference Orellana, Suzuki, Araujo and Remington1991). Inflammatory monocytes are major producers of IFN-β in mesenteric lymph nodes following oral infection of type II Prugniaud parasites in B6 mice, and mice lacking the receptor for IFN-1 (Toll-like receptors) show higher parasite loads and reduced survival (Han et al. Reference Han, Melichar, Coombes, Chan, Koshy, Boothroyd, Barton and Robey2014). Our data suggest that increased IFN-α/β levels in resistant BALB/c mice may facilitate the inhibition of T. gondii replication in this model.
In conclusion, the finding that B6 mice expressed higher levels of Gal-9 and its receptors (Tim-3 and CD137) than those in BALB/c mice after ocular T. gondii infection demonstrates that the expressions of Gal-9 and its receptors are genetically regulated in mice. However, blockage of galectin by α-lactose is not sufficient to change the ocular immunopathology in genetic resistant BALB/c mice. Deeper understanding of the role of galectins in T. gondii infection will shed new light on exploring the pathogenesis of OT. In addition, whether the markedly different expressions of IFN-α/β between intraocularly T. gondii-infected B6 and BALB/c mice are one of the mechanisms that they are genetically susceptible or resistant to the parasite needs to be further investigated.
FINANCIAL SUPPORT
This work was supported in part by grants from the Natural Science Foundation of China (no. 81471973) and the Science and Technology Planning Project of Guangdong Province, China (nos. 2014A020212108, 2013B021800043 and 2014A020212212).
CONFLICT OF INTEREST
None.